Dr. Lukas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Seattle Cancer Care Alliance - Issaquah
1740 NW Maple Street, Suite 211
Issaquah, WA 98027Phone+1 425-392-2551Fax+1 425-392-8827
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2008 - 2009- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2005 - 2007
University of WashingtonResidency, Internal Medicine, 2002 - 2005
Drexel University College of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2005 - Present
WA State Medical License 2002 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
- BGJ398 for Patients With Tumors With FGFR Genetic Alterations Start of enrollment: 2014 Jul 24
Publications & Presentations
PubMed
- 23 citationsSubgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressin...R. Connor Chick, G. Travis Clifton, Diane F. Hale, Timothy J. Vreeland, Annelies T. Hickerson
Clinical Immunology. 2021-01-22 - 57 citationsResults of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast ...G. Travis Clifton, Diane F. Hale, Timothy J. Vreeland, Annelies T. Hickerson, Jennifer K. Litton
Clinical Cancer Research. 2020-06-01 - 13 citationsInitial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer p...G. Travis Clifton, Kaitlin M. Peace, Jarrod P. Holmes, Timothy J. Vreeland, Diane F. Hale
Clinical Immunology. 2019-04-01
Press Mentions
Seattle Cancer Care Alliance Welcomed into Issaquah with Ribbon CuttingJuly 18th, 2019
Professional Memberships
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
